Medication info

Eutoral Injection 250 mg (Fluorouracil)

Prescription medicationIntravenous injection
Ingredient · strength
Fluorouracil›250mg / 1 ampoule
Manufacturer / importer
Korea United Pharm, Co., Ltd.
Appearance
Brown ampoule containing a colorless transparent liquid
Packaging
For domestic use: 5 mL/ampoule For export: 5 mL/ampoule X 1 ampoule, 5 mL/ampoule X 10 ampoules
Approval status
Active

MFDS item code 199101467 · Notified 1991.07.30

Summary

Main use
Relief of carcinomas (e.g., colon cancer), use in combination therapy (e.g., lung cancer), and malignant skin tumors
Who receives it
Adults
Adult administration
(Injection) 1. Intravenous injection (systemic administration): As monotherapy, the usual adult dose is 5~15 mg/kg body weight per day of fluorouracil (no more than 1g per infusion), dissolved in 300~500 mL of 5% dextrose injection and administered by intravenous infusion daily for 5 days. Thereafter, administer 5~7.5 mg/kg body weight by intravenous infusion every other day. Discontinue administration if adverse reactions occur. 2. Intra-arterial injection: As monotherapy, the usual adult dose is 5~7.5 mg/kg body weight per day of this drug, dissolved in 20~100 mL of 5% dextrose injection and continuously infused using an infusion pump for 10~20 days. 3. In combination with radiotherapy: The usual adult dose is 5~10 mg/kg body weight per day of this drug, administered in combination with radiotherapy in the same manner as for monotherapy. 4. In combination with other antineoplastic agents: The usual adult dose is 5~10 mg/kg body weight per day of this drug, administered in combination with other antineoplastic agents in the same manner as for monotherapy or intermittently 1~2 times per week. (Cream) Apply an appropriate amount of this drug to the affected area 1~2 times daily. In principle, occlusive dressing is preferable.

Ingredients

Manufacturer
Korea United Pharm, Co., Ltd.

Efficacy & effects

Relief of carcinomas (e.g., colon cancer), use in combination therapy (e.g., lung cancer), and malignant skin tumors

  • Colon cancer symptoms
  • rectal cancer symptoms
  • breast cancer symptoms
  • gastric cancer symptoms
  • liver cancer symptoms
  • pancreatic cancer symptoms
  • ovarian cancer symptoms
  • uterine cancer symptoms
  • esophageal cancer symptoms
  • lung cancer symptoms
  • malignant symptoms
  • tongue cancer symptoms
View approved original text

This injection is used to alleviate subjective and objective symptoms experienced by patients with various cancers such as colon cancer, rectal cancer, breast cancer, gastric cancer, liver cancer, pancreatic cancer, ovarian cancer, and uterine cancer. In addition, in the case of esophageal cancer, lung cancer, malignant melanoma, and tongue cancer, it is combined with other antitumor agents or radiation therapy to enhance therapeutic effectiveness. As a cream formulation, it is used for the treatment of skin malignant tumors such as sebaceous cell carcinoma, basal cell carcinoma, Bowen's disease, Paget's disease, radiation keratosis, and senile keratosis. Both formulations are effective in alleviating cancer-related symptoms and treating skin tumors.

How it is given

Adult administration

(Injection) 1. Intravenous injection (systemic administration): As monotherapy, the usual adult dose is 5~15 mg/kg body weight per day of fluorouracil (no more than 1g per infusion), dissolved in 300~500 mL of 5% dextrose injection and administered by intravenous infusion daily for 5 days. Thereafter, administer 5~7.5 mg/kg body weight by intravenous infusion every other day. Discontinue administration if adverse reactions occur. 2. Intra-arterial injection: As monotherapy, the usual adult dose is 5~7.5 mg/kg body weight per day of this drug, dissolved in 20~100 mL of 5% dextrose injection and continuously infused using an infusion pump for 10~20 days. 3. In combination with radiotherapy: The usual adult dose is 5~10 mg/kg body weight per day of this drug, administered in combination with radiotherapy in the same manner as for monotherapy. 4. In combination with other antineoplastic agents: The usual adult dose is 5~10 mg/kg body weight per day of this drug, administered in combination with other antineoplastic agents in the same manner as for monotherapy or intermittently 1~2 times per week. (Cream) Apply an appropriate amount of this drug to the affected area 1~2 times daily. In principle, occlusive dressing is preferable.

Precautions

Care must be taken when cutting the ampoule to prevent glass fragments from contaminating the injectable solution. Special caution is required when administering to children or the elderly. This medication should not be used in combination with certain antiviral agents due to the risk of serious hematological disorders. Additionally, when used as part of a combination therapy with other antineoplastics, it should be administered under strict medical supervision, and should only be used in emergency situations when adequate medical facilities and experienced healthcare professionals are available. Regular liver function tests are necessary, and if symptoms such as loss of appetite or fatigue occur, administration should be stopped immediately. This medication should not be used in combination with certain combination products to avoid severe side effects. It should not be administered to pregnant or potentially pregnant women, nursing mothers, or patients taking specific medications. Special considerations should be taken when administering to patients in poor nutritional status, with severe infections, liver dysfunction, kidney problems, heart disease, the elderly, and children, with particular attention to adverse reactions. This medication can cause various adverse reactions related to the nervous system, digestive system, hematopoietic system, liver, kidneys, skin, and respiratory system, and if symptoms arise, a doctor should be consulted immediately. Regular blood tests and liver and kidney function tests should be conducted to closely monitor the condition, and if abnormal findings are discovered, administration should be halted or dosages adjusted. This medication has many drug interactions; if other medications are being taken, it is essential to inform medical personnel, especially that it should not be combined with certain antiviral agents. It is preferable not to use this medication in pregnant or nursing women, and safety in pediatric patients has not been established. Overdosage may result in symptoms such as dizziness and movement disorders, so caution is required. This medication can cause skin damage at the injection site, necessitating careful administration, and when cutting ampoules, it must be done properly to avoid glass fragments. Hands should be washed thoroughly after use, and contact with eyes or mucous membranes should be avoided, while also avoiding exposure to ultraviolet light. This medication should be administered very cautiously based on the patient's condition, and if abnormal symptoms occur, immediate consultation with medical staff is required to receive appropriate care.

Side effects

Extrapyramidal symptoms, facial paralysis, speech disorder, ataxia, eye twitching, consciousness disturbances, seizures, directional sense disorder, numbness in the limbs, hallucinations, memory impairment, decreased spontaneity, urinary incontinence, leukoencephalopathy, Parkinson's symptoms, lethargy, dizziness, reversible posterior leukoencephalopathy syndrome, Wernicke's encephalopathy, loss of appetite, nausea, vomiting, diarrhea, taste changes, thirst, abdominal distension, abdominal pain, hematochezia, constipation, angular cheilitis, glossitis, severe enteritis, gastrointestinal ulcer, severe stomatitis, acute pancreatitis, pneumatosis intestinalis, small bowel colitis, colitis, lactic acidosis, tumor lysis syndrome, hypertriglyceridemia, vitamin B1 deficiency, congestive heart failure, myocardial infarction, stable angina, pain, electrocardiogram abnormalities, chest pain, chest discomfort, stress cardiomyopathy, pancytopenia, leukopenia, neutropenia, anemia, thrombocytopenia, hyperammonaemia, hepatitis, liver dysfunction, jaundice, liver failure, acute renal failure, kidney dysfunction, proteinuria, olfactory disorder, anosmia, shock, anaphylaxis symptoms, rash, shortness of breath, hypotension, interstitial pneumonia, pneumonia, sepsis, palmoplantar erythema, painful erythema and swelling, hyperesthesia, pigmentation, hair loss, edema, maceration, vesicles, itching, flushing, nail abnormalities, photosensitivity reactions, erythematous lupus, conjunctivitis, tearing, rash, arterial wall degeneration, thrombosis, fever, headache, diabetes, hypocalcemia, impaired glucose tolerance, localized vascular extravasation reaction, acute leukemia, myelodysplastic syndrome, severe pain, alopecia, aphthae, vesicular pemphigoid, malaise, ichthyosis, scales, purulence, swelling, capillary dilation, tenderness, urticaria, photodermatosis, nail discoloration, erythema, localized hemorrhage, dermatitis, nail deformity, emotional instability, insomnia, hypersensitivity reaction, stomatitis, unpleasant taste, eosinophilia, thrombocytopenia, toxic granulation, conjunctival reaction, corneal reaction, nasal irritation, herpes simplex

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be protected from light and prevented from freezing. It is recommended to store it at a temperature between 10 to 30 degrees Celsius. Storing it this way helps maintain the effectiveness of the drug safely.

Appearance and packaging

Appearance

Brown ampoule containing a colorless transparent liquid

Package unit

For domestic use: 5 mL/ampoule For export: 5 mL/ampoule X 1 ampoule, 5 mL/ampoule X 10 ampoules

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.